MODVQ — ModivCare Cashflow Statement
0.000.00%
- $0.03m
- $1.25bn
- $2.79bn
Annual cashflow statement for ModivCare, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 88.8 | -6.58 | -31.8 | -204 | -201 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 1.7 | 70.8 | 64.6 | 198 | 152 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 220 | 83.4 | -107 | -163 | -40.1 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 348 | 187 | -10.4 | -83 | -6.41 |
| Capital Expenditures | -12.2 | -21.3 | -33 | -42.3 | -27.6 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -623 | -664 | -78.8 | 0 | 0 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -635 | -686 | -112 | -42.3 | -27.6 |
| Financing Cash Flow Items | -16.2 | -14.4 | -2.98 | -0.765 | -25.9 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 408 | 449 | 3.81 | 113 | 144 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 122 | -49.9 | -118 | -12.2 | 110 |